These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 15235929

  • 1. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis.
    Osawa Y, Kawamura K, Kondo D, Imai N, Ueno M, Nishi S, Iino N, Okada M, Suzuki Y, Hoshino S, Yamazaki H, Kishimoto H, Shimada H, Yamagishi T, Ishiyama T, Narita I, Gejyo F.
    Clin Exp Nephrol; 2004 Jun; 8(2):127-33. PubMed ID: 15235929
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
    Leung N, Dispenzieri A, Fervenza FC, Lacy MQ, Villicana R, Cavalcante JL, Gertz MA.
    Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
    [Abstract] [Full Text] [Related]

  • 5. Secondary systemic amyloidosis: response and survival in 64 patients.
    Gertz MA, Kyle RA.
    Medicine (Baltimore); 1991 Jul; 70(4):246-56. PubMed ID: 2067409
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F, Ciciani AM, Santostefano M, Brugnano R, Manganaro M, Palladini G, Di Palma AM, Gallo M, Tosi PL, Salvadori M, Immunopathology Group, Italian Society of Nephrology.
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [Abstract] [Full Text] [Related]

  • 8. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.
    Uda H, Yokota A, Kobayashi K, Miyake T, Fushimi H, Maeda A, Saiki O.
    J Rheumatol; 2006 Aug; 33(8):1482-7. PubMed ID: 16881107
    [Abstract] [Full Text] [Related]

  • 9. Renal amyloidosis followed more than 5 years: report of 12 cases.
    Kaaroud H, Boubaker K, Béji S, Abderrahim E, Moussa FB, Turki S, Goucha R, Hedri H, El Younsi F, Kheder A, Maiz HB.
    Transplant Proc; 2004 Aug; 36(6):1796-8. PubMed ID: 15350480
    [Abstract] [Full Text] [Related]

  • 10. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
    Gertz MA, Leung N, Lacy MQ, Dispenzieri A, Zeldenrust SR, Hayman SR, Buadi FK, Dingli D, Greipp PR, Kumar SK, Lust JA, Rajkumar SV, Russell SJ, Witzig TE.
    Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
    [Abstract] [Full Text] [Related]

  • 11. Primary systemic amyloidosis with delayed progression to multiple myeloma.
    Rajkumar SV, Gertz MA, Kyle RA.
    Cancer; 1998 Apr 15; 82(8):1501-5. PubMed ID: 9554527
    [Abstract] [Full Text] [Related]

  • 12. Amyloidosis and cardiac involvement.
    Cacoub P, Axler O, De Zuttere D, Hausfater P, Amoura Z, Walter S, Wechsler B, Godeau P, Piette JC.
    Ann Med Interne (Paris); 2000 Dec 15; 151(8):611-7. PubMed ID: 11173703
    [Abstract] [Full Text] [Related]

  • 13. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients.
    Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA.
    Medicine (Baltimore); 2003 Sep 15; 82(5):291-8. PubMed ID: 14530778
    [Abstract] [Full Text] [Related]

  • 14. Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M.
    Rheumatology (Oxford); 2006 Jan 15; 45(1):43-9. PubMed ID: 16219644
    [Abstract] [Full Text] [Related]

  • 15. Dialysis support of patients with primary systemic amyloidosis. A study of 211 patients.
    Gertz MA, Kyle RA, O'Fallon WM.
    Arch Intern Med; 1992 Nov 15; 152(11):2245-50. PubMed ID: 1444684
    [Abstract] [Full Text] [Related]

  • 16. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N, Dispenzieri A, Lacy MQ, Kumar SK, Hayman SR, Fervenza FC, Cha SS, Gertz MA.
    Clin J Am Soc Nephrol; 2007 May 15; 2(3):440-4. PubMed ID: 17699449
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of thirty-four rheumatoid arthritis patients with renal amyloidosis, including twelve given alkylating agents.
    Couverchel L, Maugars Y, Prost A.
    Rev Rhum Engl Ed; 1995 Feb 15; 62(2):79-85. PubMed ID: 7600076
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 2006 Feb 15; 57(4):193-8. PubMed ID: 17285762
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies.
    Nasr SH, Valeri AM, Sethi S, Fidler ME, Cornell LD, Gertz MA, Lacy M, Dispenzieri A, Rajkumar SV, Kyle RA, Leung N.
    Am J Kidney Dis; 2012 Jun 15; 59(6):786-94. PubMed ID: 22417785
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug 15; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.